Overview
Ropes & Gray’s healthcare and life sciences industry group serves the legal and business needs of the world’s leading industry participants. Representing clients across all sub-sectors, our internationally-recognized team counsels pharma, biotech and medical device companies; digital health enterprises and technology companies expanding into the industry; major hospital systems, academic medical centers, and healthcare service providers; and hundreds of investors, including private equity, asset management, venture capital, and investment banking firms. Drawing on resources in our offices around the globe, which include EU and China regulatory specialists, we focus on developing cutting edge solutions to help clients meet their business goals.
Smart. Strategic. Solution-oriented. Client-friendly.
Clients trust Ropes & Gray’s healthcare and life sciences team across every aspect of their businesses:
- Mergers & Acquisitions
- Licensing, Collaborations & Joint Ventures
- Capital Markets
- Healthcare & FDA Regulatory and Compliance
- Private Equity
- Venture Capital & Emerging Companies
- Privacy & Cybersecurity
- Antitrust
- Intellectual Property
- Securities Litigation & Enforcement
- Government Enforcement
- False Claims Act
- Tax, Benefits & Executive Compensation
- Business Restructuring
- Real Estate
Global reach. Internationally recognized team.
Thought Leadership
- Reality is Tricky Business in Effective Implementation of the EU Medical Devices Regulation
- CMS Publishes Calendar Year 2023 Hospital Outpatient Payment Final Rule and Addresses 340B Drug Payments, Organ Acquisition Costs, Pandemic-Related Payment Changes, Rural Hospitals
- Enhancing Cancer Care: New CMMI Model Invites Physician Practices, Payers to Reconsider Traditional Reimbursement for Oncology Services
- New York Introduces Health Care and Mental Hygiene Worker Bonus (HWB) Program
- Congress Paves the Way for Drug Pricing Reforms with Passage of the Inflation Reduction Act of 2022
- In Bloomberg Law, Margaux Hall Discusses New Categories of Claims in Drug Price Negotiation Lawsuits
- In Westlaw Today, Health Care Attorneys Discuss New York State Office of the Medicaid Inspector General Expanded Self-Disclosure Requirements for Overpayments
- Attorneys Examine Next Frontiers in Drug Pricing and Ascendence of China as Global Player
- In Law360 and Managed Healthcare Executive, Margaux Hall Discusses Government Process on First 10 Drugs Selected for Medicare Price Negotiation
- Ropes & Gray Advises ImmunoGen in Takeda Collaboration to Develop Antibody-Drug Conjugate ELAHERE in Japan
- Steve Sencer to Present on Life Science Licensing Strategies at BIO Africa Academy in Durban, South Africa
- Deborah Gersh Moderates Markets Group Panel on Private Equity Health Care Sector Investing
- Beth Weinman Moderates International Bar Association World Life Sciences Conference Roundtable
- Tim McCrystal Moderates Private Equity New York Forum Panel on Healthcare Sector Investing
- Mark Barnes Presents at Virtual Asia Pacific Open Forum in Singapore
- Torrey McClary Named a Top Health Care Lawyer by Daily Journal
- Ropes & Gray Named The American Lawyer’s “Law Firm of the Year” and Honored for Life Sciences and Health Care
- Torrey McClary Named a Top Health Care Lawyer by Daily Journal
- Ropes & Gray Ranks Highly in 2022 LMG Life Sciences Guide
- Ropes & Gray Named “Law Firm of the Year—Pharmaceutical & Biotechnology” at The Deal Awards
